RTSN
Retension Pharmaceuticals, Inc. Common Stock
Nasdaq · usd
Retension Pharmaceuticals, Inc. Common Stock (RTSN) trades at $14.55 (-4.62%) as of 2:18:28 PM EDT on Oct 26, 2026. Market cap is $127.06M.
Stock performance
How Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock has performed from one day to one year, with its 52-week range.
- 1D
- -4.62%
- 1W
- -10.93%
- 1M
- —
- YTD
- +38.13%
- 1Y
- +38.13%
- 52-wk range
- $9.66 – $18.64
Key statistics
Today's trading snapshot for RTSN: day range, open, previous close, volume and market cap.
- Day range
- $14.55 – $15.82
- Open
- $15.13
- Prev close
- $15.25
- Volume
- 19.44K
- Market cap
- $127.06M
- Shares out
- 8.33M
8-K filings
Material corporate events Retension Pharmaceuticals, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Executive compensation changeOct 23, 2026
The Company and Mr. Wong entered into an Offer Letter establishing the terms of Mr. Wong's employment with the Company, which provides for an annual base salary of $360,000, eligibility for a discretionary bonus with a target opportunity equal to 30% of his base salary, and a sign-on bonus of $20,000.
- Charter amendmentOct 13, 2026
In connection with the closing of the Company's initial public offering (the "IPO") on October 13, 2026, the Company filed its Third Amended and Restated Certificate of Incorporation (the "Amended and Restated Certificate") with the Secretary of State of the State of Delaware on October 9, 2026. The Company's board of directors (the "Board") and stockholders previously approved the Amended and Restated Certificate to be filed in connection with, and become effective immediately prior to, the closing of the IPO.
Frequently asked questions
What is the Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock price today?
Retension Pharmaceuticals, Inc. Common Stock (RTSN) is trading at $14.55 (-4.62% on the day) as of 2:18:28 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Retension Pharmaceuticals, Inc. Common Stock?
Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
What exchange is RTSN listed on?
Retension Pharmaceuticals, Inc. Common Stock (RTSN) trades on Nasdaq in USD.
Build with AI
Build an analysis of RTSN with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a RTSN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.